144 related articles for article (PubMed ID: 5010106)
1. Maple syrup urine disease (branched-chain keto-aciduria) variant type manifesting as hyperkinetic behaviour and mental retardation. Report of two cases.
Kalyanaraman K; Chamukuttan S; Arjundas G; Gajanan N; Ramamurthi B
J Neurol Sci; 1972 Feb; 15(2):209-17. PubMed ID: 5010106
[No Abstract] [Full Text] [Related]
2. A variant form of branched-chain keto aciduria.
van der Horst JL; Wadman SK
Acta Paediatr Scand; 1971 Sep; 60(5):594-9. PubMed ID: 5125167
[No Abstract] [Full Text] [Related]
3. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
Irwin WC; Martel SB; Goluboff N
Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296
[No Abstract] [Full Text] [Related]
4. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
[No Abstract] [Full Text] [Related]
5. Family with intermittent maple syrup urine disease.
Valman HB; Patrick AD; Seakins JW; Platt JW; Gompertz D
Arch Dis Child; 1973 Mar; 48(3):225-8. PubMed ID: 4693464
[TBL] [Abstract][Full Text] [Related]
6. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family].
Sander C; Clotten R; Noetzel H; Wehinger H
Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843
[No Abstract] [Full Text] [Related]
7. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
8. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
Fischer MH; Gerritsen T
Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
[No Abstract] [Full Text] [Related]
9. M aple syrup urine disease. A review with a report of an additional case.
Schwartz JF; Kolendrianos ET
Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351
[No Abstract] [Full Text] [Related]
10. [Leucinose. II. Study of heterozygotes].
Fontaine G; Dautrevaux M; Farriaux JP; Biserte G
Lille Med; 1967 Apr; 12(4):480-3. PubMed ID: 5619112
[No Abstract] [Full Text] [Related]
11. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
Snyderman SE; Goldstein F; Sansaricq C; Norton PM
Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
13. Ketotic hypoglycaemia associated with transient branched-chain aminoacidemia.
Hambraeus L; Westphal O; Hagberg B
Acta Paediatr Scand; 1972 Jan; 61(1):81-9. PubMed ID: 5018580
[No Abstract] [Full Text] [Related]
14. [Maple syrup urine disease: report of a mild variant case and results of dietary treatment].
Stoppoloni G; Santinelli R; Prisco F; Tolone C; D'Ambrosio M
Pediatria (Napoli); 1978 Sep; 86(3):409-20. PubMed ID: 754161
[No Abstract] [Full Text] [Related]
15. [Maple syrup urine disease with an intermittent relatively benign course].
Müller H; Bickel H; Feist D; Lutz P
Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339
[No Abstract] [Full Text] [Related]
16. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
[TBL] [Abstract][Full Text] [Related]
17. An 11-day-old boy with lethargy, poor feeding, vomiting. Maple syrup urine disease.
Charrow J
Pediatr Ann; 2005 Oct; 34(10):772-4. PubMed ID: 16285630
[No Abstract] [Full Text] [Related]
18. Amino acids levels and lipid peroxidation in maple syrup urine disease patients.
Barschak AG; Sitta A; Deon M; Busanello EN; Coelho DM; Cipriani F; Dutra-Filho CS; Giugliani R; Wajner M; Vargas CR
Clin Biochem; 2009 Apr; 42(6):462-6. PubMed ID: 19121297
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of maple-syrup-urine disease for the first four days of life.
DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
[No Abstract] [Full Text] [Related]
20. Semiquantitation of leucine, isoleucine, and valine by thin-layer chromatography in management of maple-syrup urine diseases.
Allen RJ; Frey HJ; Fleming LM; Owings CL
Clin Chem; 1972 May; 18(5):413-6. PubMed ID: 5019114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
